Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 854 | 1083 | 818 | 512 | - | - |
Fund Return | -14.59% | 8.26% | -18.17% | -20.01% | - | - |
Place in category | 119 | 67 | 132 | 82 | - | - |
% in Category | 70 | 35 | 80 | 80 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
HSBC Jintrust Carbon Awareness Eq | 3.95B | 1.02 | -17.86 | 6.56 | ||
HSBC Jintrust Dynamic Strategy H | 2.91B | -1.88 | -11.99 | - | ||
HSBC Jintrust Dynamic Strategy A | 2.91B | -1.75 | -11.92 | 14.65 | ||
Jintrust Large Cap Equity Sec Inv H | 2.73B | 11.21 | -7.85 | - | ||
HSBC Jintrust Large Cap Equity Secu | 2.73B | 11.38 | -7.79 | 13.61 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Zhongou Medical and Health Hybrid A | 37.43B | -12.78 | -21.82 | - | ||
Zhongou Medical and Health Hybrid C | 37.43B | -13.36 | -22.44 | - | ||
E Healthcare Secotor | 6.35B | -4.81 | -4.29 | 9.21 | ||
Fullgoal Precision Medical Mix Fund | 4.17B | 1.88 | -10.98 | - | ||
China Southern Healthcare Balanced | 3.26B | -8.67 | -19.23 | 7.97 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Suzhou Zelgen Biopharma | CNE100003RP1 | 9.79 | 66.96 | +1.35% | |
Keymed Biosciences Inc | - | 9.63 | - | - | |
Mabwell Shanghai Bioscience | CNE100005RD2 | 9.23 | 22.92 | -2.51% | |
Jiangsu Hengrui | CNE0000014W7 | 9.17 | 48.68 | +1.93% | |
Hansoh Pharmaceutical Group | KYG549581067 | 9.01 | 18.64 | +0.32% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Neutral | Buy |
Technical Indicators | Strong Sell | BUY | Strong Sell |
Summary | Neutral | Neutral | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review